Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Oscar Health Inc (OSCR) vs Vanguard Intermediate Term Corporate Bond ETF (VCIT) Price & Performance

Oscar Health IncTrade
Vanguard Intermediate Term Corporate Bond ETFTrade

Price performance (Past 24H)

Key statistics

Oscar Health Inc vs Vanguard Intermediate Term Corporate Bond ETF — how do they compare? Oscar Health Inc trades at $33.36 (market cap $10.22B), while Vanguard Intermediate Term Corporate Bond ETF trades at $78.4 (market cap $72.20B). The key difference: Vanguard Intermediate Term Corporate Bond ETF is far larger — about 7.1× Oscar Health Inc's market cap, and Oscar Health Inc is trading nearer its 52-week high, Vanguard Intermediate Term Corporate Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Oscar Health Inc for 15 Days and Vanguard Intermediate Term Corporate Bond ETF for 62 Days on average.

OSCRVCIT
Market Cap
$10.22B$72.20B
Volume
4,123,3947,532,796
Sector
HealthFixed Income
52-Week High
$33.81$84.82
52-Week Low
$10.85$77.98
Typical Hold Time
15 Days62 Days
Enterprise Value
$6.57B—

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Oscar Health Inc

OSCR trades at $33.41, up 1.52% today, with a bullish technical signal and strong recent earnings beats in Q1 and Q2 2026. The stock shows robust revenue growth, with 2026 revenue projected at $15.3B and a return to profitability. Analyst sentiment is mixed but leans positive, with a consensus price target of $34.00. Recent news highlights market share gains and raised 2026 guidance, though the stock faces tests from rising medical costs.

The outlook is cautiously optimistic, driven by scalable growth in the ACA market and margin expansion opportunities. Key risks include medical cost pressures and competitive threats. Upside potential exists if the company executes on its 2029 EPS target of $4+, but investors should monitor profitability sustainability amid cost headwinds.

Vanguard Intermediate Term Corporate Bond ETF

VCIT (Vanguard Intermediate-Term Corporate Bond ETF) trades at $78.385, up 0.15% with a bearish technical signal from moving averages. The ETF maintains consistent $0.34 dividend payments and shows institutional interest with recent purchases by Engineers Gate Manager LP and HB Wealth Management. Technical indicators show mixed signals with RSI at neutral levels while ADX indicates strong trend momentum.

The ETF offers a compelling 4.8% yield with low 0.03% expense ratio, positioning it favorably against competitors. However, the bearish technical outlook and interest rate sensitivity present near-term risks. Long-term income investors may find value in VCIT's investment-grade corporate bond exposure despite current market volatility.

Returns comparison

Trailing returns across standard periods

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR →

About Vanguard Intermediate Term Corporate Bond ETF

VCIT tracks the Bloomberg U.S. 5-10 Year Corporate Bond Index, providing exposure to investment-grade debt from industrial, utility, and financial companies. It acts as a middle-ground bond fund, offering higher yields than short-term bonds with less price volatility than long-term corporate debt.

Read more on VCIT →